Jasper Therapeutics Inc. (JSPR)
NASDAQ: JSPR
· Real-Time Price · USD
3.07
0.04 (1.32%)
At close: Aug 15, 2025, 3:59 PM
3.05
-0.65%
After-hours: Aug 15, 2025, 06:15 PM EDT
Jasper Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 39.51M | 48.8M | 71.64M | 92.5M | 106.82M | 118.47M | 86.89M | 103.87M | 115.81M | 129.4M | 38.25M | 50.95M | 60.81M | 70.4M | 84.7M | 100.91M | 309.73K | 590.61K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 345K | 345K | 100.13M | 100.2M |
Other Long-Term Assets | 192K | 532K | 820K | 1.01M | 1.16M | 1.42M | 1.34M | 411K | 445K | 725K | 1.18M | 543K | 577K | 611K | 990K | n/a | -4.05M | -3.65M |
Receivables | n/a | n/a | n/a | 250K | 250K | 250K | 250K | 268K | 330K | n/a | n/a | 384K | 443K | 563K | n/a | 298K | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 672K | 1.77M | 1.87M | n/a | -384K | 2M | 2.81M | -698K | 1.19M | n/a | n/a |
Other Current Assets | 3.46M | 854K | 646K | 625K | 475K | 440K | 309K | -261K | 653K | 1.45M | 1.87M | n/a | 27K | 54K | 837K | 37K | 103.58K | 161.65K |
Total Current Assets | 42.97M | 53.17M | 75.81M | 94.81M | 108.68M | 120.31M | 88.94M | 105.22M | 118.57M | 132.51M | 41.73M | 52.41M | 63.29M | 73.8M | 87.83M | 102.41M | 422.93K | 756.8K |
Property-Plant & Equipment | 2.89M | 3.47M | 2.85M | 3.18M | 3.67M | 3.81M | 4.19M | 4.36M | 4.74M | 5.11M | 5.45M | 5.74M | 6.09M | 5.72M | 4.83M | 4.46M | 4.05M | 3.65M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -980K | n/a | n/a | n/a | -668K | n/a | n/a | n/a |
Total Long-Term Assets | 3.5M | 4.42M | 4.09M | 4.61M | 5.25M | 5.66M | 6.44M | 5.19M | 5.6M | 6.25M | 6.63M | 6.7M | 7.08M | 6.75M | 5.82M | 4.81M | 100.13M | 100.2M |
Total Assets | 46.47M | 57.6M | 79.9M | 99.41M | 113.93M | 125.96M | 94.89M | 110.41M | 124.17M | 138.76M | 48.36M | 59.11M | 70.37M | 80.55M | 93.65M | 107.21M | 100.55M | 100.96M |
Account Payables | 8.03M | 3M | 4.03M | 3.09M | 2.96M | 2.39M | 4.15M | 3.26M | 1.58M | 3.85M | 1.77M | 3.12M | 3M | 1.47M | 3.92M | 2.25M | 4.61M | 1.35M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.08M | n/a | n/a | n/a | n/a | n/a | 2.81M | 5.55M | n/a | n/a |
Short-Term Debt | 1.95M | n/a | n/a | n/a | n/a | 1M | 972K | 945K | 917K | 891K | n/a | 840K | 784K | 521K | n/a | 490K | n/a | n/a |
Other Current Liabilities | 8.37M | 1.83M | 3.7M | 8.31M | 467K | -499K | 4.51M | -525K | 400K | 1.76M | 194K | 1.41M | 1.31M | 3.01M | 2.44M | 1.1M | -8.41M | -3.06M |
Total Current Liabilities | 20.5M | 12.33M | 15.24M | 12.46M | 10.07M | 8.92M | 12.37M | 11.91M | 8.97M | 7.89M | 7.07M | 7.42M | 6.62M | 5.97M | 8.02M | 9.16M | 328.93K | 180.77K |
Long-Term Debt | 201K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M | 2.3M | 2.68M | 3.11M | 2.52M | 1.11M | 1.73M | 3.09M | 13.74M | 16.94M | 11.29M | 8.24M |
Total Long-Term Liabilities | 2.46M | 3.02M | 2.99M | 3.27M | 3.55M | 3.82M | 2.3M | 4.37M | 4.99M | 5.67M | 5.31M | 4.12M | 4.96M | 6.47M | 16.12M | 19.45M | 13.93M | 10.92M |
Total Liabilities | 22.96M | 15.35M | 18.23M | 15.73M | 13.62M | 12.73M | 16.45M | 16.27M | 13.96M | 13.56M | 12.37M | 11.54M | 11.59M | 12.44M | 24.14M | 28.61M | 14.26M | 11.1M |
Total Debt | 2.15M | 2.59M | 1.81M | 2.07M | 2.32M | 2.55M | 2.79M | 3.01M | 3.23M | 3.44M | 3.65M | 3.85M | 4.02M | 3.9M | 2.88M | 3M | 2.64M | 2.68M |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 11K | 11K | 11K | 4K | 4K | 4K | 4K | 4K | 4K | 81.29M | 84.86M |
Retained Earnings | -288.83M | -262.11M | -240.87M | -216.55M | -197.91M | -183.33M | -169.6M | -153.02M | -135.47M | -119.39M | -105.14M | -91.92M | -80.06M | -69.66M | -67.45M | -58.39M | -5.15M | -1.58M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | 0.00 | n/a | 0.00 | -0.00 | n/a | -107.21M | 0.00 | -151.11M |
Shareholders Equity | 23.5M | 42.24M | 61.67M | 83.68M | 100.31M | 113.23M | 78.44M | 94.13M | 110.2M | 125.2M | 35.99M | 47.56M | 58.78M | 68.11M | 69.52M | 78.6M | 86.29M | 89.86M |
Total Investments | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 417K | 345K | 345K | 100.13M | 100.2M |